# US 2026/0233214 A1 · Cationic Polymers And Methods Of Making Same, And Uses Thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0233214 A1
- Document ID: US20260233214A1
- Status: Published application
- Kind: A1
- Application number: 19/157,431
- Filed: 2024-02-20
- Published: 2026-08-13
- Earliest claimed: 2023-02-17
- Assignees: Cornell University; Carnegie Mellon University
- Applicants: Cornell University; Carnegie Mellon University
- Inventors: Brett P. Fors; Geoffrey W. Coates; Jesse H. Hsu; Cheyenne Peltier; Cassandra Ann Haynes; Kevin J.T. Noonan
- Web page: https://patentgrep.com/patent/US20260233214A1

## CPC

- B01J 41/14: obtained by reactions only involving unsaturated carbon-to-carbon bonds
- C07D 295/037: with quaternary ring nitrogen atoms
- B01J 41/05: in the strongly basic form
- C07C 211/63: having quaternised nitrogen atoms bound to acyclic carbon atoms
- C07D 233/58: with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
- C07F 9/062: {Organo-phosphoranes without P-C bonds}
- C08F 232/08: having condensed rings (coumarone-indene polymers C08F244/00)
- C08F 297/06: using a catalyst of the coordination type
- C07C 2602/42: the bicyclo ring system containing seven carbon atoms
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)
- C08F: MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS

## Abstract

Cationic compounds and methods of making and using same. A cationic compound comprises one or more norbornenyl group(s) and one or more cationic group(s). The cationic groups(s) is/are chosen from phosphonium groups, imidazolium groups, cyclic ammonium groups, and the like, and any combination thereof. The cationic group(s) is/are independently covalently linked or covalently linked via a linking group to the norbornene ring of a norbornenyl group. In various examples, one or more cationic compound(s) is/are used as a monomer or monomers in a polymerization, such as, for example, a direct insertion polymerization or the like, to form a cationic polymer. In various examples, an anionic exchange membrane, which may be used in a device, such as, for example, in a sensor, an actuator, an energy-storage device, or an energy-generating device, or the like, comprising one or more cationic polymer(s).

## Claims

### Claim 1

A cationic compound comprising one or more norbornenyl group(s) and at least one cationic group, wherein each cationic group is independently at each occurrence chosen from phosphonium groups, imidazolium groups, cyclic ammonium groups, and wherein each cationic group is directly covalently linked or linked via a linking group to a norbornene ring of a norbornenyl group.

### Claim 2 (depends on 1)

The cationic compound of claim 1, wherein each cationic group is directly covalently linked or linked via a linking group to the norbornene ring via a carbon other than a carbon of a carbon-carbon double bond of the norbornenyl group and/or each cationic group is directly covalently linked or linked via a linking group to the norbornene ring via a carbon at an endo or exo position other than a carbon of the carbon-carbon double bond of the norbornenyl group.

### Claim 3 (depends on 1)

The cationic compound of claim 1, wherein each phosphonium group independently comprises a following structure:
or a structural analog thereof, wherein
R1 is independently at each occurrence chosen from H group, alkyl groups, cyclic alkyl groups, and, aryl groups; and
X− is an anion or a complex anion.

### Claim 4 (depends on 1)

The cationic compound of claim 1, wherein each imidazolium group independently comprises a following structure:
or a structural analog thereof, wherein
R2 is independently at each occurrence chosen from H group, alkyl groups, cyclic alkyl groups, and aryl groups; and
X− is an anion or a complex anion.

### Claim 5 (depends on 1)

The cationic compound of claim 1, wherein each cyclic ammonium group independently comprises a following structure:
or a structural analog thereof, wherein
(i) R3, R4, and an ammonium nitrogen (N+) taken together form a heterocyclic group, wherein N+ is a member of a heterocyclic ring of the heterocyclic group and R5 is an aliphatic or aryl group, or (ii) R3, R4, R5, and N taken together form an aliphatic group-bridged heterocyclic group, wherein N+ is a member of a heterocyclic ring of the aliphatic group-bridged heterocyclic group; and
X− is an anion or a complex anion.

### Claim 6 (depends on 1)

The cationic compound of claim 1, wherein at least a portion or all of the cationic group(s) comprise a complex anion independently chosen from BF4−, SbF6−, SbCl6−, PF6−, B(Ar)4−, wherein Ar is an aryl group, (ArF)4−, wherein ArF is an aryl group substituted with one, two, three, four, or five fluorine group(s) or one, two, three, four, or five fluoroalkyl group(s), and NTf2−, wherein Tf is a triflate group.

### Claim 7 (depends on 1)

The cationic compound of claim 1, wherein the cationic compound comprises 2, 3, 4, or 5 cationic groups covalently linked to a norbornenyl group.

### Claim 8 (depends on 1)

The cationic compound of claim 1, wherein the cationic compound comprises at least two cationic groups covalently linked directly to each other via a linking group.

### Claim 9 (depends on 1)

The cationic compound of claim 1, wherein the cationic compound comprises at least two cationic groups, wherein a first cationic group is covalently linked to a norbornenyl group and one or more second cationic groups(s) covalently linked to the first cationic group, wherein at least one of the cationic groups is a phosphonium group or an imidazolium group.

### Claim 10 (depends on 1)

The cationic compound of claim 1, wherein the cationic compound comprises two cationic groups linked directly to each other via an aliphatic group, a heterocyclic group, wherein at least one N atom is quaternary, or a bridged heterocyclic group, wherein at least one N atom is quaternary atom of a first quaternary ammonium group and an aliphatic group, a heterocyclic group, wherein at least one N atom is a quaternary atom of second quaternary ammonium group, or a bridged heterocyclic group, where in at least one N atom is quaternary atom of a second quaternary group.

### Claim 11 (depends on 1)

The cationic compound of claim 1, wherein the cationic compound comprises 2, 3, 4, or 5 norbornenyl groups covalently linked to a cationic group.

### Claim 12 (depends on 1)

The cationic compound of claim 1, wherein the cationic compound comprises a cationic group and at least two norbornenyl groups,
wherein each of the norbornenyl groups are directly covalently linked or linked via a linking group to the cationic group.

### Claim 13 (depends on 1)

The cationic compound of claim 1, wherein the cationic group comprises a cyclic cationic group fused to a norbornenyl group.

### Claim 14 (depends on 1)

The cationic compound of claim 1, wherein the cationic compound comprises a following structure:
wherein n is 1, 2, 3, or 4, or a structural analog thereof.

### Claim 15 (depends on 1)

The cationic compound of claim 1, wherein the cationic compound comprises a following structure:
or a structural analog thereof, or a salt, a partial salt, a solvate, or a polymorph thereof, or a stereoisomer or a mixture of stereoisomers, an isotopic variant, or a tautomer thereof, wherein
R is independently at each occurrence chosen from H group, alkyl group, cationic group chosen from phosphonium groups, imidazolium groups, and cyclic ammonium groups,
with a proviso that at least one R group is a cationic group.

### Claim 16 (depends on 1)

The cationic compound of claim 1, wherein the cationic compound comprises a following structure:
or a structural analog thereof, or a structural analog thereof, or a salt, a partial salt, a solvate, or a polymorph thereof, or a stereoisomer or a mixture of stereoisomers, an isotopic variant, or a tautomer thereof.

### Claim 17 (depends on 16)

The cationic compound of claim 16, wherein an R group of the structure is in an endo or exo position.

### Claim 18

(canceled)

### Claim 19

(canceled)

### Claim 20

(canceled)

### Claim at position 21

-47. (canceled)
